Archive for January, 2008
« Previous EntriesPharmaGossip has just had a VIP visitor
Submitted by PharmaGossip Blog
Shhh! Can’t say who!
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Thursday’s Top Biotech & Medical Stocks
Submitted by BioHealth Investor
Biotechnology
ATHERSYS INC [ATHX] +14.16%
SUNESIS PHARMACEUTIC [SNSS] +14.04%
NILE THERAPEUTICS [NILT.OB] +11.76%
CRITICAL THERAPEUTIC [CRTX] +11.21%
COMBINATORX [CRXX] +11.04%
Diagnostic Substances
SYNTA PHARMACEUTICAL [SNTA] +10.06%
GENELABS TECH INC [GNLB] +8.03%
IMARX THERAPEUTICS [IMRX] +7.25%
ROSETTA GENOMICS LTD [ROSG] +6.65%
CNS RESPONSE, INC. [CNSO.OB] +3.96%
Drug Delivery
PENWEST PHARM CO [PPCO] +7.16%
BIOVAIL CORP [BVF] +4.50%
ARADIGM CORP [ARDM.OB] +4.17%
ACURA PHARMACEUTICAL [ACPH.OB] +3.17%
COLUMBIA LABS INC [...]
BioWatch Stock Alert: Somanetics Jumps on Volume Spike
Submitted by BioHealth Investor
Shares of Somanetics Corp (SMTS) jumped 6.82% on Thursday as volume surged almost three times the three-month daily average!
There were no news or any significant events that could be detected.
Somanetics develops, manufacturs, and markets medical devices primarily in the United States. It offers the INVOS System, a non-invasive patient monitoring system that [...]
Tested on the young, used on the old
Submitted by BioHealth Investor, Health business blog
Ever notice that medical devices are tested on non-Medicare populations and then paid for mostly by Medicare? Dr. Rita F. Redberg did. See (Medicare coverage decisions often based on trials in irrelevant populations)
“I was appointed to the [Medicare Evidence Development and Coverage Advisory Committee] MedCAC in 2002, and [...]
McCain is the FrontRunner - The Tea Leaves for Pharma
Submitted by BioHealth Investor, Eye On FDA
Last night, John McCain won the Florida primary, clearly putting him in the status of front runner in the Republican Party. Hillary Clinton won Florida, even though that is an empty victory as far as delegates, she is trying to make it into something, and perhaps it does count [...]
Amaze your friends!
Submitted by PharmaGossip Blog
Break the ice at parties!
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Sanofi Aventis - Ketek: subpoenas ahoy!
Submitted by PharmaGossip Blog
Another chapter in the tale of Sanofi-Aventis’ Ketek has opened with the news that the US Congress is to subpoena documents from members of the government and the Food and Drug Administration in connection with a review of the controversial antibiotic.
The House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations [...]
Just to avoid confusion
Submitted by PharmaGossip Blog
Story
The story seems to be very popular with US medical school departments, judging by PharmaGossip’s stat counter!
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Blowing my own trumpet?
Submitted by PharmaGossip Blog
Insider has tried it - he can’t reach!
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Viva Zyprexa! - Lilly have some nerve
Submitted by PharmaGossip Blog
How might one define hypocrisy?
Lilly’s CEO-in-waiting chides the NYT whilst at the same time trying to settle with federal prosecutors for $1 billion!
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
GSK - Avandia: Dr Haffner is busted
Submitted by PharmaGossip Blog
A leading member of the Senate said Wednesday that a prominent diabetes expert had leaked an unpublished and confidential medical journal article to GlaxoSmithKline last year, tipping the company to the imminent publication of safety questions involving the company’s diabetes drug Avandia.
The expert, Dr. Steven M. Haffner of the University of [...]
EU Hedge: Pharmion and Celgene
Submitted by BioHealth Investor, CLSDF
A very interesting few days for Pharmion (NASDAQ: PHRM) and Celgene (NASDAQ: CELG) and how they are faring in their product approval efforts in Europe.
The European Medicines Agency issued a positive opinion to recommend approval of Pharmion’s Thalidomide® for use in combination with melphalan and prednisone as first line treatment for [...]
Schering-Plough Relief on Partner Earnings
Submitted by BioHealth Investor, 24/7 Wall St.
Schering-Plough Corp. (SGP) is probably breathing a sigh of relief this morning after Merck’s earnings as it is partners with the drug giant on Vytorin and Zetia for cholesterol treatments.
The combined Vytorin & Zetia franchise was noted as having some $5.2 Billion in 2007 annual sales, with some $1.5 [...]
Wednesday’s Top Biotech & Medical Stocks
Submitted by BioHealth Investor
Biotechnology
ONCOTHYREON [ONTY] +48.06%
METABASIS THERAPEUTI [MBRX] +30.86%
IMMUNOSYN CORPORATIN [IMYN.OB] +16.67%
PLURISTEM THERAPEUTC [PSTI] +14.17%
HESKA CORPORATION [HSKA] +10.53%
Diagnostic Substances
IMMUCELL CP [ICCC] +9.48%
SCOLR PHARMA INC [DDD] +7.14%
AVALON PHARMACEUTIC [AVRX] +7.05%
EPICEPT CORPORATION [EPCT] +6.77%
GENELABS TECH INC [GNLB] +4.58%
Drug Delivery
ELAN CP PLC ADR [ELN] +2.88%
BENTLEY PHARMACEUTIC [BNT] +2.17%
GENEREX BIOTECH CORP [GNBT] +0.01%
Drug Manufacturers
AVANIR PHARMACEUTICL [AVNR] [...]
Vytorin - who knew what and when?!
Submitted by PharmaGossip Blog
Peter Rost is causing more tremors!
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Vytorin contd. - Merck’s Dick Clark has a message
Submitted by PharmaGossip Blog
The chief executive of Merck has told Reuters that negative media coverage of the ENHANCE trial of the company’s blockbuster Vytorin cholesterol drug has unfairly overlooked benefits of the medicine.
“With media hype, there is a great deal of confusion,” Richard Clark told analysts in a conference call after release of the [...]
WuXi PharmaTech Puts Squeeze on Suppliers
Submitted by BioHealth Investor, ChinaBio Today
WuXi PharmaTech (WX) held a conference yesterday with its suppliers. Following a classic good-news/bad-news theme, the Shanghai-based CRO told its suppliers that it expected to increase spending between 50% and 100%, but at the same time, the company asked suppliers for better terms: longer payment periods, quality guarantees and lower [...]
Statins - who needs them and why?
Submitted by PharmaGossip Blog
The NYT’s Tara Parker Pope investigates:
But many statin users don’t have established heart disease; they simply have high cholesterol. For healthy men, for women with or without heart disease and for people over 70, there is little evidence, if any, that taking a statin will make a meaningful difference in how [...]
Homoeopathy - the end is nigh!
Submitted by PharmaGossip Blog
At long last UK NHS primary care trusts are slashing funding for homoeopathic treatment amid debate about its efficacy and the drive to cuts costs, a study has suggested.
More than a quarter have stopped or cut funding for such services, research by the GP magazine Pulse has found.
The Royal [...]
Floridians say: “So long Rudy”
Submitted by PharmaGossip Blog
Hat tip: http://ideagrove.com/blog/
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
FDA - Hear hear!
Submitted by PharmaGossip Blog
All is not well at the FDA.
Commish Andy had to listen to four hours of “critique”.
“I think we’ve had a cascade of serious warning signs that the levies are leaking,” Garret. FitzGerald of the University of Pennsylvania, a member of the agency’s Science Board, tells the paper. “We need to respond [...]
Tuesday’s Top Biotech & Medical Stocks
Submitted by BioHealth Investor
Biotechnology
OPEXA THERAPEUTICS [OPXA] +27.39%
STEMCELLS INC [STEM] +19.09%
CARDIOVASCULAR BIOTH [CVBT.OB] +13.91%
COMPUGEN LTD [CGEN] +13.87%
GTC BIOTHERAP INC [GTCB] +11.65%
Diagnostic Substances
INTERLEUKIN GENETICS [ILI] +9.08%
ABAXIS INC [ABAX] +4.31%
IDEXX LABS [IDXX] +3.72%
SYNTA PHARMACEUTICAL [SNTA] +3.67%
AMAG PHARMACEUTICALS [AMAG] +2.88%
Drug Delivery
PENWEST PHARM CO [PPCO] +26.17%
ELAN CP PLC ADR [ELN] +4.88%
ACURA PHARMACEUTICAL [ACPH.OB] +4.00%
COLUMBIA LABS INC [CBRX] +3.33%
NOVEN [...]
What does FDA stand for?
Submitted by PharmaGossip Blog
Fundamentally Defective Agency
Here’s why Dr David Graham should be Commish!
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Todays new word is:
Submitted by PharmaGossip Blog
Pajamahadeen
Visit 1800blogger to see all of our industry leading blogs.
Rating 3.00 out of 5
[?]
Crestor vs Vytorin - John Mack spots the irony
Submitted by PharmaGossip Blog
Who says Americans can’t “do irony”!
John Mack has a great post about AZ trying to replace Vytorin with Crestor!
The irony:
The ENHANCE and METEOR studies are similar in one respect: each studied only a few hundred people over a limited time period. Merck and Schering-Plough are trying to say we shouldn’t [...]
